is semaglutide shortage over RACGP FDA says shortage of Ozempic – Federal judge upholds FDA's removal

Constipation is a GLP-1 side effect, not an insulin side effect

Seeley: On average, about two-thirds of the weight will come back in the year after you stop

However, individuals with hepatic or renal dysfunction, seizure disorders, or those undergoing oncological care should seek medical guidance before use

These symptoms typically occur during treatment initiation or dose escalation and often diminish over several weeks as tolerance develops

Neither figure is tied to a named analysis anywhere in the article, so both are best read as unattributed summaries rather than verified rates

But for a root-cause, gut-centered practice like mine, a few recent developments keep them near the bottom of my list